(Q40679805)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11677002%20AND%20SRC:MED&resulttype=core&format=json

2 December 2019

title

Inter- and intraindividual variability of riluzole serum concentrations in patients with ALS (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11677002%20AND%20SRC:MED&resulttype=core&format=json

amyotrophic lateral sclerosis

2 December 2019

main subject

1 reference

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11677002%20AND%20SRC:MED&resulttype=core&format=json

2 December 2019

6

J H Wokke

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11677002%20AND%20SRC:MED&resulttype=core&format=json

2 December 2019

Leonard H van den Berg

7

object named as

L H van den Berg

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11677002%20AND%20SRC:MED&resulttype=core&format=json

2 December 2019

author name string

G J Groeneveld

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11677002%20AND%20SRC:MED&resulttype=core&format=json

2 December 2019

H J van Kan

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11677002%20AND%20SRC:MED&resulttype=core&format=json

2 December 2019

J S Toraño

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11677002%20AND%20SRC:MED&resulttype=core&format=json

2 December 2019

J H Veldink

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11677002%20AND%20SRC:MED&resulttype=core&format=json

2 December 2019

publication date

1 October 2001

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11677002%20AND%20SRC:MED&resulttype=core&format=json

Journal of the Neurological Sciences

2 December 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11677002%20AND%20SRC:MED&resulttype=core&format=json

2 December 2019

volume

191

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11677002%20AND%20SRC:MED&resulttype=core&format=json

2 December 2019

issue

1-2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11677002%20AND%20SRC:MED&resulttype=core&format=json

2 December 2019

page(s)

121-125

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11677002%20AND%20SRC:MED&resulttype=core&format=json

The pharmacology and mechanism of action of riluzole

2 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2801%2900613-X

Neuroprotective effects of riluzole in ALS CSF toxicity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2801%2900613-X

Protective effect of riluzole on excitatory amino acid-mediated neurotoxicity in motoneuron-enriched cultures

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2801%2900613-X

Benefit of vitamin E, riluzole, and gabapentin in a transgenic model of familial amyotrophic lateral sclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2801%2900613-X

A controlled trial of riluzole in amyotrophic lateral sclerosis. ALS/Riluzole Study Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2801%2900613-X

A confirmatory dose-ranging study of riluzole in ALS. ALS/Riluzole Study Group-II.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2801%2900613-X

Single- and multiple-dose pharmacokinetics of riluzole in white subjects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2801%2900613-X

Population pharmacokinetics of riluzole in patients with amyotrophic lateral sclerosis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2801%2900613-X

Disposition of fluvoxamine in humans is determined by the polymorphic CYP2D6 and also by the CYP1A2 activity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2801%2900613-X

Pharmacogenetics and adverse drug reactions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2801%2900613-X

Simultaneous determination of flucytosine and fluorouracil in human plasma by high-performance liquid chromatography

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2801%2900613-X

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2801%2900613-X

Riluzole: a new agent for amyotrophic lateral sclerosis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2801%2900613-X

Neuroprotective strategies in a model of chronic glutamate-mediated motor neuron toxicity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2801%2900613-X

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0022-510X(01)00613-X

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11677002%20AND%20SRC:MED&resulttype=core&format=json

2 December 2019

1 reference